Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI

PHASE4CompletedINTERVENTIONAL
Enrollment

681

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Percutaneous Coronary Intervention
Interventions
DRUG

Yangxinshi

Yangxinshi pill 3 pills /tid

DRUG

Trimetazidine

Trimetazidine 20mg/tid

DRUG

Yangxinshi mimic

Yangxinshi mimic tablets 3 pills /tid

DRUG

Trimetazidine mimic

Trimetazidine mimic tablets 20mg/tid

Trial Locations (15)

110016

General Hospital of Northern Theater Command, Shenyang

Unknown

The First Affiliated Hospital of University of Science and Technology of China, Hefei

Beijing Anzhen Hospital, Capital Medical University, Beijing

Peking University People's Hospital, Beijing

The First Affiliated Hospital of Chongqing Medical University, Chongqing

Guangdong Provincial People's Hospital, Guangzhou

Cangzhou Central Hospital, Cangzhou

Hebei General Hospital, Shijiazhuang

Changchun Traditional Medicine University Affiliated Hospital, Changchun

The Second Hospital of Dalian Medical University, Dalian

Jinan Central Hospital Affiliated to Shandong University, Jinan

Shandong Provincial Hospital, Jinan

Qingdao Municipal Hospital, Qingdao

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

First Hospital of Shanxi Medical University, Taiyuan

All Listed Sponsors
lead

Shenyang Northern Hospital

OTHER

NCT03809273 - Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI | Biotech Hunter | Biotech Hunter